Literature DB >> 9924312

Allergic eye disease mechanisms.

J I McGill1, S T Holgate, M K Church, D F Anderson, A Bacon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9924312      PMCID： PMC1722368          DOI： 10.1136/bjo.82.10.1203

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  102 in total

1.  ANTIBODIES TO GRASS IN VERNAL CONJUNCTIVITIS.

Authors:  M ALLANSMITH; O L FRICK
Journal:  J Allergy       Date:  1963 Nov-Dec

2.  Prevalence of asthma in adults in Busselton, Western Australia.

Authors:  J K Peat; M Haby; J Spijker; G Berry; A J Woolcock
Journal:  BMJ       Date:  1992-11-28

3.  Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis.

Authors:  T C Stokes; G Feinberg
Journal:  Clin Exp Allergy       Date:  1993-09       Impact factor: 5.018

4.  Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis.

Authors:  S Bonini; N P Barney; M Schiavone; M Centofanti; A Berruto; S Bonini; M R Allansmith
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

5.  Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis.

Authors:  M Leino; K Ennevaara; A L Latvala; P Nordgren; A M Posti; R Suves; E Takalo
Journal:  Clin Exp Allergy       Date:  1992-10       Impact factor: 5.018

6.  Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine.

Authors:  Y Okayama; R C Benyon; P H Rees; M A Lowman; K Hillier; M K Church
Journal:  Clin Exp Allergy       Date:  1992-03       Impact factor: 5.018

7.  The c-kit receptor ligand functions as a mast cell chemoattractant.

Authors:  C J Meininger; H Yano; R Rottapel; A Bernstein; K M Zsebo; B R Zetter
Journal:  Blood       Date:  1992-02-15       Impact factor: 22.113

8.  Demand incidence and episode rates of ophthalmic disease in a defined urban population.

Authors:  J H Sheldrick; S A Vernon; A Wilson; S J Read
Journal:  BMJ       Date:  1992-10-17

9.  Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis.

Authors:  M Blumenthal; T Casale; R Dockhorn; I Jarmoszuk; H Kaiser; R Smith; H J Zeitz
Journal:  Am J Ophthalmol       Date:  1992-01-15       Impact factor: 5.258

10.  Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.

Authors:  G T Fahy; D L Easty; L M Collum; A Benedict-Smith; M Hillery; D G Parsons
Journal:  Eur J Ophthalmol       Date:  1992 Jul-Sep       Impact factor: 1.922
View more
  12 in total

Review 1.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

2.  Allergic conjunctivitis and nasal allergy.

Authors:  Zdenek Pelikan
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

3.  Vernal keratoconjunctivitis: culmination of management using immunosuppression, surgical and prosthetic therapy over quarter century.

Authors:  Shilpa Das; Anand S Pasari; Virender S Sangwan
Journal:  BMJ Case Rep       Date:  2016-11-23

Review 4.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

Review 5.  A review of the use of olopatadine in allergic conjunctivitis.

Authors:  James I McGill
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

Review 6.  Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.

Authors:  Leonard Bielory; C H Katelaris; Susan Lightman; Robert M Naclerio
Journal:  MedGenMed       Date:  2007-08-15

7.  Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.

Authors:  M Daniell; M Constantinou; H T Vu; H R Taylor
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

8.  Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis.

Authors:  Kaijun Li; Xialin Liu; Ziyan Chen; Qiang Huang; Kaili Wu
Journal:  Mol Vis       Date:  2010-10-14       Impact factor: 2.367

9.  Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines.

Authors:  Najam A Sharif; Shouxi Xu; Peggy E Hellberg; Iok-Hou Pang; Daniel A Gamache; John M Yanni
Journal:  Mol Vis       Date:  2009-06-06       Impact factor: 2.367

10.  Nasal-ocular reflexes and their role in the management of allergic rhinoconjunctivitis with intranasal steroids.

Authors:  Fuad M Baroody; Robert M Naclerio
Journal:  World Allergy Organ J       Date:  2011-01       Impact factor: 4.084
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.